<DOC>
	<DOCNO>NCT01112982</DOCNO>
	<brief_summary>The purpose study show patient gout suffer chronic inflammation joint , observable MRI , even absence symptomatic gouty attack . Secondary end-points study include analyze effect uric acid-lowering therapy ( specifically FDA approve medication Febuxostat ) subgroup patient , check presence inflammatory marker see correlation propose chronic inflammation , evaluate characteristic finding gout MRI .</brief_summary>
	<brief_title>An Assessment Chronic Synovial-Based Inflammation Its Role With Serum Urate Levels .</brief_title>
	<detailed_description>The clinical history untreated gout transition acute intermittent arthritis chronic inflammatory arthritis . This tell u point inflammation associate gout abate . Our group recently complete advanced imaging study patient early gout suggest nearly 60 % subject synovial pannus intercritical gout . This likely prevalent patient advance gout . The presence synovial pannus also likely correlate serum urate level . The primary aim study determine percentage patient know gout evidence chronic ongoing synovial-based inflammatory disease , determine degree inflammation , correlate serum urate level . Secondary endpoint include assessment presence characteristic finding gout MRI ( i.e . erosive change , intraosseous tophus , soft tissue tophus , joint effusion , bone marrow edema , soft tissue edema ) . We also check serum high-sensitivity CRP level evaluate correlation synovial pannus , assess baseline radiograph `` index '' joint presence erosive change , correlate presence severity synovial pannus joint . Analysis also perform see correlation serum urate level . A sub-study perform assess effect aggressive serum urate lowering therapy ( specifically febuxostat [ Uloric ] ) chronic inflammation ; i.e . synovial pannus .</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Colchicine</mesh_term>
	<mesh_term>Febuxostat</mesh_term>
	<mesh_term>Uric Acid</mesh_term>
	<criteria>1 . Age &gt; = 18 Open end male female . 2 . Have know history gout diagnose current previous documentation intracellular MSU crystal synovial fluid , tophus prove contain MSU crystal , least six twelve ACR diagnostic criterion gout ( see appendix 12 diagnostic criterion gout ) . 3 . English Spanish speaking 4 . Able give inform consent 1 . Age &lt; 18 . 2 . Unable give inform consent . 3 . Do speak write English Spanish . 4 . History inflammatory arthritis . 5 . History another crystal induce arthritis . 6 . Serum creatinine &gt; 1.8 mg/dL 7 . Patients take oral corticosteroid ( dose ) [ within 4 week ] 8 . Parenteral intraarticular corticosteroid within 6 week 9 . Allergy gadolinium contrast dye 10 . Any contraindication receive MRI 11 . Pregnant woman 12 . Allergy febuxostat ( Uloric ) colchicine [ substudy subject ]</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Gout</keyword>
	<keyword>Synovial pannus</keyword>
	<keyword>Magnetic resonance imaging</keyword>
</DOC>